Literature DB >> 21214578

Reducing costs in flow-cytometric counting of residual white blood cells in blood products: utilization of a single-platform bead-free flow-rate calibration method.

Johannes C Fischer1, Ernst M Quenzel, Rainer Moog, Folker Wenzel, Regina Riethmacher, Boris Tutschek, Günther Giers.   

Abstract

BACKGROUND: Commercial flow-cytometric methods for counting residual white blood cells (rWBCs) in leukoreduced blood products use calibration beads for estimation of the measured sample volume. A bead-free flow-rate calibration method is developed and validated. STUDY DESIGN AND METHODS: The analyzed volume was calculated by acquisition time (ACQ). Twenty-nine spiking series of red blood cell (RBC) or platelet (PLT) products were prepared containing levels ranging from 0.08 × 10(6) up to 2048 × 10(6) WBCs/L. Nearly WBC-free triple-leukofiltered RBCs or PLT concentrates (PCs) served as background. Propidium iodide (PI) was used to identify rWBCs. Five RBC series were compared against a commercially available kit (LeukoSure, Beckman Coulter). Routine capabilities were tested on 41 RBC and 92 PC samples of two independent transfusion services.
RESULTS: The lower detection limit in RBC was 0.08 × 10(6) rWBCs/L for ACQ and 0.16 for LeukoSure. Criteria for linearity, accuracy, and precision were fulfilled within the range of 0.5 × 10(6) to 512 × 10(6) WBCs/L. For PCs, all these criteria were fulfilled between 0.5 × 10(6) and 32 × 10(6) rWBCs/L (lower detection limit of 0.25) for PI. ACQ and LeukoSure agreed sufficiently (81%) when tested on routine RBCs or PCs.
CONCLUSION: A residual WBC count of fewer than 0.5 × 10(6) WBCs/L can be accurately counted using the ACQ approach at a total reagent cost of less than 0.5€ per sample.
© 2010 American Association of Blood Banks.

Entities:  

Mesh:

Year:  2011        PMID: 21214578     DOI: 10.1111/j.1537-2995.2010.02998.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  2 in total

1.  Broad-spectrum antibiotic or G-CSF as potential countermeasures for impaired control of bacterial infection associated with an SPE exposure during spaceflight.

Authors:  Minghong Li; Veronica Holmes; Houping Ni; Jenine K Sanzari; Ana L Romero-Weaver; Liyong Lin; Alejandro Carabe-Fernandez; Eric S Diffenderfer; Ann R Kennedy; Drew Weissman
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

2.  Hindlimb suspension and SPE-like radiation impairs clearance of bacterial infections.

Authors:  Minghong Li; Veronica Holmes; Yu Zhou; Houping Ni; Jenine K Sanzari; Ann R Kennedy; Drew Weissman
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.